Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Live Nation Entertainment, Zeta Global, and more By Investing.com
    News

    Live Nation Entertainment, Zeta Global, and more By Investing.com

    userBy user2024-11-11No Comments1 Min Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email



    After-Hours Stock Movers:

    Live Nation Entertainment (NYSE:) rose 5% after it reported third quarter earnings per share that beat estimates. The company announced the highest ever concerts profitability with adjusted operating income of $474 million, up 39%, and margins of 7.2%.

    Zeta Global Holdings Corp. (ZETA) fell 8% despite delivering record revenue of $268M, an increase of 42% year-over-year, and raising full year guidance.

    Neurogene (NGNE) fell 35% after it reported interim clinical data in the first four participants in the low-dose cohort of its ongoing Phase 1/2 open-label trial designed to evaluate NGN-401 gene therapy for the treatment of female pediatric patients with Rett syndrome.

    IAC/Interactive Corp (IAC) rose 2% despite mixed third quarter results, after it said it is exploring a spinoff of its 85% ownership in Angi Inc. (ANGI) to IAC shareholders.





    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleTrump taps Lee Zeldin for EPA, Rep. Elise Stefanik for UN post
    Next Article Monitor Your Car Battery to Prevent Sudden Failures and Ensure Long-Term Performance
    user
    • Website

    Related Posts

    This FTSE stock just rocketed over 10% on strong results. Time to consider buying?

    2026-01-23

    Dow Jones near 50,000: is it too late to invest?

    2026-01-23

    Up 170% and 470% in a year, will these 2 red-hot FTSE shares soar again in 2026?

    2026-01-23
    Add A Comment

    Leave a ReplyCancel reply

    © 2026 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d